Sort
8,912 grants matching “sars cov 2”
Semiparametric Regression Analysis of Interval-Censored Data in Current Cohort Studies
$396,020Donglin Zeng · University Of Michigan At Ann Arbor · R01 · FY2024 · HL
Develop novel inhaled neutralizing RNA therapeutics against COVID-19
$396,000John Joseph Rossi · Beckman Research Institute/City Of Hope · R21 · FY2021 · AI
Project 2: Susceptibility of Lung Cancer Cells to SARS- CoV-2 Infection and Antibody-Mediated Neutralization
$395,967Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · U54 · FY2022 · CA
Endophenotype Network-based Approaches to Prediction and Population-based Validation of in Silico Drug Repurposing for Alzheimer's Disease
$395,914Feixiong Cheng · Cleveland Clinic Lerner Com-Cwru · R01 · FY2020 · AG
Innate Immune Responses to SARS-CoV-2 in AD mouse models
$395,791Qizhi Gong · University Of California At Davis · R01 · FY2023 · DC
SARS-CoV-2 and HIV-1 Interactions with C-Type Lectins
$395,790Vineet N Kewalramani · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Modeling viral entry and its inhibition using SARS-CoV
$395,225Graham Simmons · Vitalant · R01 · FY2012 · AI
Modeling viral entry and its inhibition using SARS-CoV
$395,225Graham Simmons · Vitalant · R01 · FY2011 · AI
MCA: Understanding the animal movement and disease transmission interface
$395,122Meggan E Craft · University Of Minnesota-Twin Cities · · FY2023 · BIO
CEIRR: COVID-19 Research Activities
$395,086Andrew Pekosz · Johns Hopkins University · N01 · FY2022 · AI
CEIRR: COVID-19 Research Activities
$395,086Andrew S. Pekosz · Johns Hopkins University · N01 · FY2023 · AI
The Role of Eicosanoid-PPAR axis in Exacerbating Post-Influenza Staphylococcus aureus Super-infection
$395,008Vincent Tam · Temple Univ Of The Commonwealth · R01 · FY2024 · AI
Production of protein array for serum antibody screening
$395,000Leonidas C Platanias · Northwestern University At Chicago · P30 · FY2020 · CA
Cancer Center Administration
$395,000Aleksandar Zafirovski · Northwestern University At Chicago · P30 · FY2020 · CA
The Role of Eicosanoid-PPAR axis in Exacerbating Post-Influenza Staphylococcus aureus Super-infection
$394,974Vincent Tam · Temple Univ Of The Commonwealth · R01 · FY2025 · AI
Midwestern changes in substance use and treatment during the COVID-19 pandemic
$394,655Lisa M McFadden · Sanford Research/Usd · P20 · FY2022 · GM
When pandemics collide: The intersection of the opioid crisis, COVID-19 and HIV pandemics among people who inject drugs in the United States
$394,272Becky Lynn Genberg · Johns Hopkins University · R01 · FY2024 · DA
Development and significance of the plasma cell niche in the human infant thymus
$394,144Emmanuel Zorn · Columbia University Health Sciences · U01 · FY2020 · AI
CORE 2: Technology Core
$393,837Danielle L Swaney · University Of California, San Francisco · U19 · FY2024 · AI
Mechanistic characterization of SARS-CoV2 associated kidney injury
$393,750Deborah J Lenschow · Washington University · R01 · FY2022 · DK
Mechanistic characterization of SARS-CoV2 associated kidney injury
$393,750Deborah J Lenschow · Washington University · R01 · FY2021 · DK
Development and characterization of engineered therapeutic antibodies against SARS-CoV-2
$393,750Gaya K. Amarasinghe · Washington University · R01 · FY2022 · AI
Mechanistic characterization of SARS-CoV2 associated kidney injury
$393,750Deborah J Lenschow · Washington University · R01 · FY2023 · DK
SocioEnvironmental & Ecological Disparities Group: Identifying the Health Impacts of Dynamic Inequities
$393,654Francisco Alejandro Montiel Ishino · National Institute Of Environmental Health Sciences · ZIA · FY2023 · ES
Temple University Gastroparesis Clinical Center
$393,626Henry P. Parkman · Temple Univ Of The Commonwealth · U01 · FY2023 · DK